Evidence Hub

Amiodarone-induced aseptic meningitis

Janssens L, Van Daele W, Schotsmans K

BMJ case reports, 2026

Abstract

Drug-induced aseptic meningitis (DIAM) is a rare but serious adverse drug reaction. A broad spectrum of medications is linked to DIAM, with NSAIDs, human IVIG, antibiotics (particularly sulphonamides and penicillins), vaccines and monoclonal antibodies being among the most frequently reported. Amiodarone is a frequently used anti-arrhythmic medication and neurotoxic effects including tremor and peripheral neuropathy are well known. We present a case of a male in his late 70s admitted to the emergency department with a 5-week history of headache, vomiting and weight loss. Cerebrospinal fluid analysis was suggestive of aseptic meningitis. The symptoms emerged after initiation of amiodarone and showed rapid resolution on withdrawal of the medication. To the best of our knowledge, this is the first case to describe aseptic meningitis induced by amiodarone.

How strong is the evidence?

Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free